Page last updated: 2024-09-02

1-hydroxymethylmidazolam and fexofenadine

1-hydroxymethylmidazolam has been researched along with fexofenadine in 1 studies

Compound Research Comparison

Studies
(1-hydroxymethylmidazolam)
Trials
(1-hydroxymethylmidazolam)
Recent Studies (post-2010)
(1-hydroxymethylmidazolam)
Studies
(fexofenadine)
Trials
(fexofenadine)
Recent Studies (post-2010) (fexofenadine)
1634649700226256

Protein Interaction Comparison

ProteinTaxonomy1-hydroxymethylmidazolam (IC50)fexofenadine (IC50)
Histamine H1 receptorHomo sapiens (human)0.0623

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frye, RF; Himmelfarb, J; Le, P; Leblond, FA; Naud, J; Nolin, TD; Pichette, V; Sadr, H1

Other Studies

1 other study(ies) available for 1-hydroxymethylmidazolam and fexofenadine

ArticleYear
ESRD impairs nonrenal clearance of fexofenadine but not midazolam.
    Journal of the American Society of Nephrology : JASN, 2009, Volume: 20, Issue:10

    Topics: Adult; Aged; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood Urea Nitrogen; Cytochrome P-450 CYP3A; Enterocytes; Female; Hepatocytes; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Midazolam; Middle Aged; Organic Anion Transporters; Prospective Studies; Rats; Rats, Sprague-Dawley; Terfenadine

2009